| Literature DB >> 36235325 |
Aifan Wang1, Lei Kang2, Guangsheng Yang1, Zaiyun Li1.
Abstract
Brassica napus inap cytoplasmic male sterility (CMS) is a novel sterile line with potential application in rapeseed hybrid breeding. Sterile cytoplasm was obtained from Isatis indigotica through somatic fusion and then recurrent backcrossing with B. napus. Previous studies have shown that inap CMS abortion occurred before the stamen primordia (stage 4-5), but the genetic mechanism of sterility needs to be studied. RNA-seq analyses were performed on the floral buds at two stages (0-5 and 6-8), before and after the formation of stamen primordium. As a result, a total of 1769 and 594 differentially expressed genes (DEGs) were detected in the CMS line compared to its maintainer line at the two stages, respectively. In accordance with the CMS phenotype, the up- and downstream regulators of the stamen identity genes AP3 and PI were up- and downregulated in the CMS line, respectively. Furthermore, isobaric tags for relative and absolute quantitation (iTRAQ) analysis showed that a total of 760 differentially abundant proteins (DAPs) were identified in flower buds at stages 0-8, and most of the proteins related to the anther development, oxidative phosphorylation, and programmed cell death (PCD) were downregulated in inap CMS. In combined transcriptomic and proteomic analysis, a total of 32 DEGs/DAPs were identified, of which 7 common DEGs/DAPs had the same expression trend at stage 0-8 of flower development. The downregulation of genes related to the energy deficiency, hormone signal transduction, and the maintenance of mitochondrial metabolic homeostasis at stage 0-5 might disturb the normal differentiation of stamen primordium, resulting in carpelloid stamen of inap CMS. The study will help provide insights into the molecular mechanism of this new male sterility.Entities:
Keywords: Brassica napus; PCD; cytoplasmic male sterility; energy deficiency; iTRAQ; transcriptome
Year: 2022 PMID: 36235325 PMCID: PMC9571993 DOI: 10.3390/plants11192460
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Flower morphology of inap CMS (D–G) and its maintainer “H3” (A–C) in B. napus. (A,D) Flowers; (B,F) Floral buds without sepals and petals. (E) Carpelloid stamen of inap CMS. (C,G) Flower buds at the stages 0–8. Red asterisks mark stage 6–8 buds. Bars: 1 mm.
Figure 2The analysis of DEGs. (A) Venn diagram of DEGs at stages 0–5 and 6–8 of flower development in inap CMS and H3; (B) GO annotation analysis of common DEGs at stages 0–5 and 6–8. Red and green bars represent up- and downregulated genes in inap CMS, respectively. BP, biological process. CC, cellular component. MF, molecular function.
Figure 3KEGG pathway significant enrichment analysis of DEGs at stage 0–5 (A), 6–8 (B), and both periods (C).
Figure 4Analysis of differentially abundant proteins (DAPs) in floral buds of inap CMS line compared with its maintainer line H3. (A) Volcano plot of DAPs between inap CMS vs. H3. (B) The top 50 GO Terms with significant enrichment of DAPs. Red and green bars represent up- and downregulated proteins in inap CMS, respectively. MF, molecular function. CC, cellular component. BP, biological process. (C) KEGG significant enrichment analysis of DAPs. Red and blue bars represent up- and downregulated proteins in inap CMS, respectively.
The main proteins involved in the occurrence of sterility in inap CMS.
| DAPs_ID | Description | Mean_Ratio | TAIR_ID | |
|---|---|---|---|---|
| Carpel and ovule development | ||||
| BnaA09g12770D | Elongation factor G, chloroplastic | 1.53 | 0.0206 | AT1G62750 |
| BnaA05g11640D | Transcription factor TCP10 | 1.43 | 0.0067 | AT2G31070 |
| BnaC06g12160D | O-acyltransferase WSD1 | 1.37 | 0.0196 | AT5G37300 |
| BnaC05g44320D | Arogenate dehydratase/prephenate dehydratase 2, chloroplastic | 1.31 | 0.0001 | AT3G07630 |
| BnaC03g36730D | ABC transporter I family member 6, chloroplastic | 1.29 | 0.0458 | AT3G10670 |
| Anther and pollen development | ||||
| BnaAnng09150D | Protein SHI RELATED SEQUENCE 5 | 0.74 | 0.0462 | AT1G75520 |
| BnaC05g00110D | Squamosa promoter-binding-like protein 8 | 0.72 | 0.0031 | AT4G39400 |
| BnaC01g09870D | Piriformospora indica-insensitive protein 2 | 0.56 | 0.0012 | AT1G13230 |
| BnaA07g08200D | Pollen-specific protein-like | 0.48 | 0.0054 | AT4G18596 |
| BnaA03g58200D | Pollen-specific protein-like | 0.37 | 0.0061 | AT4G18596 |
| Pectinesterase | ||||
| BnaC02g00700D | Probable pectinesterase/pectinesterase inhibitor 51 | 0.8 | 0.0004 | AT5G09760 |
| BnaA02g00180D | Probable pectinesterase/pectinesterase inhibitor 51 | 0.72 | 0.0419 | AT5G09760 |
| Polygalacturonase | ||||
| BnaA05g29810D | Exopolygalacturonase clone GBGA483 | 0.63 | 0.0002 | AT3G07850 |
| BnaA05g26870D | Polygalacturonase inhibitor 1 | 0.65 | 0.0142 | AT5G06860 |
| Oxidative phosphorylation | ||||
| BnaA05g04190D | Acyl carrier protein 1, mitochondrial | 0.82 | 0.0247 | AT2G44620 |
| BnaC02g16510D | Acyl carrier protein 2, mitochondrial | 0.81 | 0.0217 | AT1G65290 |
| BnaC02g04760D | ATP synthase subunit O, mitochondrial | 0.7 | 0.0279 | AT5G13450 |
| BnaC04g43510D | ATP synthase subunit gamma, mitochondrial | 0.68 | 0.0232 | AT2G33040 |
| BnaC07g32820D | ATP synthase subunit d, mitochondrial | 0.67 | 0.0311 | AT3G52300 |
| BnaA03g04340D | ATP synthase subunit O, mitochondrial | 0.56 | 0.0229 | AT5G13450 |
| BnaC08g23600D | ATP synthase subunit d, mitochondrial | 0.53 | 0.0239 | AT3G52300 |
| PCD | ||||
| BnaA07g09120D | Glutathione S-transferase U13 | 0.75 | 0.0199 | AT1G27130 |
| BnaC03g69760D | Persulfide dioxygenase ETHE1 homolog, mitochondrial | 0.75 | 0.0050 | AT1G53580 |
| BnaC09g09340D | Thioredoxin reductase 2 | 0.72 | 0.0176 | AT2G17420 |
| BnaC01g25910D | Thioredoxin M3, chloroplastic | 0.68 | 0.0022 | AT2G15570 |
| BnaC08g42050D | Thioredoxin-like protein CXXS1 | 0.52 | 0.0131 | AT1G11530 |
| BnaA09g54380D | Peroxidase 22 | 0.75 | 0.0320 | AT2G38380 |
| BnaA10g24240D | Peroxidase 53 | 0.61 | 0.0217 | AT5G06720 |
| BnaC08g24170D | Peroxiredoxin-2E, chloroplastic | 0.74 | 0.0111 | AT3G52960 |
| In order of Mean_Ratio ( | ||||
Figure 5Real-time PCR confirmation of the relative expression of genes encoding 12 DAPs between inap CMS and its maintainer line (H3). All data are shown as the mean ± SD from three independent biological replicates. Significance at 0.01 < p < 0.05 level was marked with “*”; at p < 0.01 level was marked with “**”; while at p > 0.05 level was no marker which indicated no significant difference between inap CMS and H3.
Figure 6The Venn diagram of proteomic (iTRAQ) and transcriptomic (RNA-seq) analysis for the similarities and differences of DAPs/DEGs. (A) Conjoint analysis of proteins and transcripts showing unique and shared DAPs/DEGs. (B) and (C) up- and downregulated DAPs/DEGs at 0–5 and 6–8 periods in inap CMS, respectively.
Figure 7Differential abundance protein species (DAPs) involved in pathways related to carbohydrate and energy metabolism. Each pathway was surrounded by the dotted line in different colors. Purple words indicate the enzymes catalyzed in the relevant pathway. Red letters represent the upregulated and green letters represent the downregulated protein in inap CMS.